ArticleVaccine: X2024

Cost-effectiveness analysis of NVX-CoV2373 COVID-19 vaccination for elderly people in Japan.

Masafumi Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.